Skip to main content

ADVERTISEMENT

contrast-induced nephropathy (CIN)

Original Contribution
03/14/2019

Lorenzo Azzalini, MD, PhD, MSc1;  Alessandra Laricchia, MD1,2;  Damiano Regazzoli, MD1,3;  Satoru Mitomo, MD1,4; Daisuke Hachinohe, MD1,5;  Barbara Bellini, MD1;  Ozan M. Demir, MBBS1,6;  Enrico Poletti, MD1; Davide Maccagni, RT1;  Antonio Colombo, MD1,2

Lorenzo Azzalini, MD, PhD, MSc1;  Ale...
We aimed to evaluate the feasibility of an ultra-low contrast volume percutaneous coronary intervention protocol in patients with severe chronic kidney disease.
We aimed to evaluate the feasibility of an ultra-low contrast volume percutaneous coronary intervention protocol in patients with severe chronic kidney disease.
We aimed to evaluate the...
03/14/2019
Journal of Invasive Cardiology
Original Contribution
05/15/2015

Jake M. Chanin, MD, MSc*;  David C. Yang, MD*;  Muhammad A. Haider, MD;  Rajesh V. Swaminathan, MD; Luke K. Kim, MD;  Konstantinos Charitakis, MD;  Michael Tanoue, MD;  Robert M. Minutello, MD; Christopher L. Gade, MD;  Harsimran S. Singh, MD;  Geoffrey Bergman, MD; S. Chiu Wong, MD;  Dmitriy N. Feldman, MD

Jake M. Chanin, MD, MSc*;  David C. Y...
Following percutaneous coronary intervention (PCI), elevations in serum creatinine level and declines in glomerular filtration rate are common. Prior studies have demonstrated benefit of chronic statin therapy in the prevention of...
Following percutaneous coronary intervention (PCI), elevations in serum creatinine level and declines in glomerular filtration rate are common. Prior studies have demonstrated benefit of chronic statin therapy in the prevention of...
Following percutaneous coronary...
05/15/2015
Journal of Invasive Cardiology